PAREXEL International Stock Price, News & Analysis (NASDAQ:PRXL)

Previous CloseN/A
Today's RangeN/A
52-Week Range$51.16 - $88.10
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio42.97
Dividend YieldN/A
BetaN/A

About PAREXEL International (NASDAQ:PRXL)

PAREXEL International logoPAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.

Receive PRXL News and Ratings via Email

Sign-up to receive the latest news and ratings for PRXL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryLife Sciences Tools & Services
SectorHealthcare
SymbolNASDAQ:PRXL
CUSIP69946210
Phone+1-781-4879900

Debt

Debt-to-Equity Ratio1.01%
Current Ratio1.45%
Quick Ratio1.45%

Price-To-Earnings

Trailing P/E Ratio42.9658536585366
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$2.05
Net IncomeN/A
Net Margins4.62%
Return on Equity19.95%
Return on Assets5.29%

Miscellaneous

Employees18,900
Outstanding Shares51,120,000

PAREXEL International (NASDAQ:PRXL) Frequently Asked Questions

What is PAREXEL International's stock symbol?

PAREXEL International trades on the NASDAQ under the ticker symbol "PRXL."

How were PAREXEL International's earnings last quarter?

PAREXEL International Co. (NASDAQ:PRXL) issued its quarterly earnings results on Wednesday, October, 26th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by $0.10. The medical research company earned $500.90 million during the quarter, compared to the consensus estimate of $525.15 million. PAREXEL International had a net margin of 4.62% and a return on equity of 19.95%. The company's quarterly revenue was down 2.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.70 earnings per share. View PAREXEL International's Earnings History.

Where is PAREXEL International's stock going? Where will PAREXEL International's stock price be in 2018?

6 Wall Street analysts have issued twelve-month target prices for PAREXEL International's shares. Their forecasts range from $75.00 to $88.10. On average, they anticipate PAREXEL International's share price to reach $82.52 in the next year. View Analyst Ratings for PAREXEL International.

Who are some of PAREXEL International's key competitors?

Who are PAREXEL International's key executives?

PAREXEL International's management team includes the folowing people:

  • Josef H. von Rickenbach, Chairman of the Board, Chief Executive Officer
  • Mark A. Goldberg M.D., President, Chief Operating Officer
  • Simon Harford, Chief Financial Officer, Senior Vice President
  • , Bio & Compensation - 
  • Xavier AB Flinois, President - PAREXEL Informatics
  • Michelle Graham, Chief Human Resource Officer, Senior Vice President
  • Sybrand Pretorius M.D., Senior Vice President, Chief Scientific Officer
  • Douglas Alexander Batt, Senior Vice President, General Counsel, Secretary
  • Roland Andersson Ph.d., Senior Vice President - Clinical Research Services
  • Christian Dreger Ph.D., Senior Vice President - Parexel Access and Parexel Consulting
  • , Bio & Compensation - 
  • David J. Godwin, Senior Vice President-Global Business

How do I buy PAREXEL International stock?

Shares of PAREXEL International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact PAREXEL International?

PAREXEL International's mailing address is 195 West St, WALTHAM, MA 02451-1111, United States. The medical research company can be reached via phone at +1-781-4879900.


MarketBeat Community Rating for PAREXEL International (PRXL)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  289 (Vote Outperform)
Underperform Votes:  402 (Vote Underperform)
Total Votes:  691
MarketBeat's community ratings are surveys of what our community members think about PAREXEL International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PAREXEL International (NASDAQ:PRXL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $82.52$78.30$78.30$73.71
Price Target Upside: 5.43% downside10.26% downside10.26% downside15.52% downside

PAREXEL International (NASDAQ:PRXL) Consensus Price Target History

Price Target History for PAREXEL International (NASDAQ:PRXL)

PAREXEL International (NASDAQ:PRXL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/21/2017Jefferies GroupReiterated RatingHold$88.10LowView Rating Details
6/20/2017BarclaysDowngradeOverweighr -> Equal Weight$87.00HighView Rating Details
6/20/2017Raymond James FinancialUpgradeUnderperform -> Mkt PerformHighView Rating Details
6/6/2017Credit Suisse GroupReiterated RatingNeutral$65.00 -> $83.00LowView Rating Details
5/30/2017MizuhoBoost Price TargetBuy -> Buy$66.00 -> $75.00LowView Rating Details
5/23/2017Goldman Sachs GroupUpgradeSell -> Neutral$63.00 -> $77.00LowView Rating Details
5/15/2017Evercore ISIUpgradeIn-Line -> Outperform$85.00LowView Rating Details
2/3/2017Deutsche BankDowngradeHold -> Sell$66.00 -> $53.00N/AView Rating Details
2/3/2017CitigroupDowngradeBuy -> NeutralN/AView Rating Details
11/23/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
11/17/2016First AnalysisDowngradeOverweight -> Equal Weight$62.00N/AView Rating Details
11/11/2016SunTrust BanksDowngradeBuy -> Hold$80.00 -> $60.00N/AView Rating Details
10/27/2016Robert W. BairdDowngradeOutperform -> Neutral$78.00 -> $67.00N/AView Rating Details
7/18/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
5/22/2016KeyCorpReiterated RatingHoldN/AView Rating Details
4/11/2016Avondale PartnersLower Price TargetUnderperform$50.50 -> $49.00N/AView Rating Details
(Data available from 2/25/2016 forward)

Earnings

PAREXEL International (NASDAQ:PRXL) Earnings History and Estimates Chart

Earnings by Quarter for PAREXEL International (NASDAQ:PRXL)

PAREXEL International (NASDAQ PRXL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/28/2017Q4 2017$0.94$1.02$537.59 million$557.20 millionViewN/AView Earnings Details
5/3/2017Q3 2017$0.73$0.74$529.38 million$529.30 millionViewListenView Earnings Details
2/1/2017Q2 2017$0.83$0.85$537.37 million$534.40 millionViewN/AView Earnings Details
10/26/2016Q117$0.86$0.76$525.15 million$500.90 millionViewListenView Earnings Details
8/3/2016Q416$0.93$0.94$532.41 million$538.60 millionViewListenView Earnings Details
4/27/2016Q316$0.90$0.89$523.16 million$527.10 millionViewListenView Earnings Details
1/27/2016Q2$0.72$0.90$523.03 million$518.50 millionViewListenView Earnings Details
10/28/2015Q116$0.63$0.70$511.77 million$512.10 millionViewListenView Earnings Details
8/5/2015Q415$0.74$0.79$527.13 million$523.00 millionViewListenView Earnings Details
4/29/2015Q315$0.66$0.66$513.50 million$502.03 millionViewListenView Earnings Details
1/28/2015Q215$0.60$0.69$502.20 million$499.27 millionViewListenView Earnings Details
10/30/2014Q115$0.58$0.65$505.60 million$491.69 millionViewListenView Earnings Details
8/7/2014Q414$0.62$0.65$508.99 million$510.60 millionViewListenView Earnings Details
4/29/2014Q314$0.54$0.56$493.35 million$492.40 millionViewListenView Earnings Details
1/30/2014Q214$0.49$0.49$479.49 million$487.10 millionViewListenView Earnings Details
10/30/2013Q114$0.45$0.45$458.94 million$449.20 millionViewListenView Earnings Details
8/7/2013Q4 2013$0.43$0.50$455.23 million$463.10 millionViewListenView Earnings Details
4/30/2013Q3 2013$0.40$0.50$438.10 million$454.49 millionViewListenView Earnings Details
1/29/2013Q2 2013$0.33$0.41$419.78 million$422.10 millionViewListenView Earnings Details
10/30/2012Q113$0.29$0.29$396.70 million$394.80 millionViewN/AView Earnings Details
8/8/2012Q4 2012$0.29$0.34ViewN/AView Earnings Details
4/30/2012$0.31$0.33ViewN/AView Earnings Details
1/30/2012$0.23$0.23ViewN/AView Earnings Details
10/31/2011$0.15$0.20ViewN/AView Earnings Details
8/9/2011$0.07$0.10ViewN/AView Earnings Details
5/2/2011$0.30$0.27ViewN/AView Earnings Details
1/31/2011$0.28$0.28ViewN/AView Earnings Details
11/1/2010Q1 2011$0.28$0.30ViewN/AView Earnings Details
8/9/2010Q4 2010$0.30$0.32ViewN/AView Earnings Details
4/27/2010Q3 2010$0.27$0.28ViewN/AView Earnings Details
1/25/2010Q2 2010$0.22$0.26ViewN/AView Earnings Details
10/27/2009Q1 2010$0.17$0.21ViewN/AView Earnings Details
8/10/2009Q4 2009$0.27$0.11ViewN/AView Earnings Details
4/27/2009Q3 2009$0.23$0.25ViewN/AView Earnings Details
1/26/2009Q2 2009$0.20$0.23ViewN/AView Earnings Details
10/27/2008Q1 2009$0.22$0.23ViewN/AView Earnings Details
8/6/2008Q4 2008$0.26$0.28ViewN/AView Earnings Details
4/23/2008Q3 2008$0.22$0.24ViewN/AView Earnings Details
1/23/2008Q2 2008$0.20$0.20ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

PAREXEL International (NASDAQ:PRXL) Earnings Estimates

2018 EPS Consensus Estimate: $3.86
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$0.85$0.94$0.88
Q2 20185$0.93$0.99$0.96
Q3 20185$0.94$0.98$0.97
Q4 20184$1.04$1.10$1.06
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for PAREXEL International (NASDAQ:PRXL)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

PAREXEL International (NASDAQ PRXL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.90%
Institutional Ownership Percentage: 87.45%
Insider Trades by Quarter for PAREXEL International (NASDAQ:PRXL)
Institutional Ownership by Quarter for PAREXEL International (NASDAQ:PRXL)

PAREXEL International (NASDAQ PRXL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/3/2017Sybrand PretoriusSVPSell8,050$65.12$524,216.009,950View SEC Filing  
2/9/2017Gadi SaaronyInsiderSell2,325$64.54$150,055.5014,208View SEC Filing  
8/15/2016Gadi SaaronyInsiderSell2,500$70.05$175,125.009,417View SEC Filing  
8/9/2016Joshua SchultzSVPSell2,500$68.64$171,600.005,168View SEC Filing  
6/13/2016A Dana Callow JrDirectorSell3,000$60.04$180,120.0034,072View SEC Filing  
6/2/2016Eduard E HoldenerDirectorSell700$62.98$44,086.0012,471View SEC Filing  
5/25/2016Ulf I SchneiderSVPSell7,500$62.00$465,000.0035,030View SEC Filing  
5/24/2016Ulf I SchneiderSVPSell6,000$61.00$366,000.0033,530View SEC Filing  
5/23/2016Ulf I SchneiderSVPSell6,000$60.01$360,060.0033,530View SEC Filing  
5/20/2016Ulf I SchneiderSVPSell8,000$59.24$473,920.0035,530View SEC Filing  
3/30/2016Richard L LoveDirectorSell1,330$62.50$83,125.0084,110View SEC Filing  
12/1/2015Richard L LoveDirectorSell1,330$68.21$90,719.3085,440View SEC Filing  
11/24/2015Eduard E HoldenerDirectorSell2,200$67.66$148,852.0013,171View SEC Filing  
11/12/2015Gadi SaaronySVPSell12,425$67.01$832,599.2511,917View SEC Filing  
11/11/2015Patrick J FortuneDirectorSell1,500$68.07$102,105.0024,653View SEC Filing  
9/1/2015Richard L LoveDirectorSell1,330$64.26$85,465.8084,350View SEC Filing  
8/18/2015Mark A GoldbergCOOSell8,995$73.49$661,042.55View SEC Filing  
8/18/2015Thomas SenderovitzSVPSell1,500$74.02$111,030.00View SEC Filing  
6/18/2015Mark A GoldbergCOOSell11,507$70.03$805,835.21View SEC Filing  
5/14/2015Richard L LoveDirectorSell5,000$65.00$325,000.00View SEC Filing  
3/19/2015Mark A GoldbergCOOSell12,884$68.99$888,867.16View SEC Filing  
3/2/2015A Dana Callow JrDirectorSell2,000$65.84$131,680.00View SEC Filing  
2/19/2015Christopher J LindopDirectorSell2,000$63.59$127,180.00View SEC Filing  
2/13/2015Rickenbach Josef H VonCEOSell65,100$62.53$4,070,703.00View SEC Filing  
2/6/2015Eduard E HoldenerDirectorSell3,000$62.97$188,910.00View SEC Filing  
2/4/2015Douglas A BattSVPSell8,300$60.89$505,387.00View SEC Filing  
2/3/2015Gadi SaaronyVPSell8,525$60.97$519,769.25View SEC Filing  
12/3/2014Mark A GoldbergCOOSell25,345$58.99$1,495,101.55View SEC Filing  
11/5/2014Christopher J LindopDirectorSell12,000$55.00$660,000.00View SEC Filing  
8/20/2014Gadi SaaronyVPSell6,075$57.78$351,013.50View SEC Filing  
8/18/2014Anita CooperVPSell4,916$57.56$282,964.96View SEC Filing  
8/15/2014Anita CooperVPSell5,084$57.50$292,330.00View SEC Filing  
8/14/2014Anita CooperVPSell6,800$57.54$391,272.00View SEC Filing  
8/13/2014Mark A GoldbergCOOSell16,761$56.33$944,147.13View SEC Filing  
8/11/2014Richard L LoveDirectorSell6,000$57.33$343,980.00View SEC Filing  
6/5/2014Patrick J FortuneDirectorSell3,000$53.04$159,120.00View SEC Filing  
2/20/2014Anita CooperVPSell2,500$53.00$132,500.0023,286View SEC Filing  
2/18/2014Mark GoldbergCOOSell11,206$52.49$588,202.94105,088View SEC Filing  
2/12/2014Mark GoldbergCOOSell12,199$50.49$615,927.51105,088View SEC Filing  
2/11/2014Anita CooperVPSell10,000$50.00$500,000.0023,286View SEC Filing  
2/10/2014Eduard HoldenerDirectorSell6,000$49.62$297,720.0013,289View SEC Filing  
2/10/2014Rickenbach Josef VonCEOSell50,000$49.76$2,488,000.00562,641View SEC Filing  
2/7/2014Gadi SaaronyVPSell9,950$49.56$493,122.008,700View SEC Filing  
2/7/2014Rickenbach Josef VonCEOSell50,000$49.70$2,485,000.00612,641View SEC Filing  
2/4/2014Christopher LindopDirectorSell10,000$49.00$490,000.0029,593View SEC Filing  
2/3/2014Douglas BattSVPSell8,000$48.58$388,640.0060,457View SEC Filing  
2/3/2014Mark GoldbergCOOSell13,529$48.70$658,862.30105,088View SEC Filing  
1/13/2014Mark GoldbergCOOSell6,957$48.90$340,197.30118,617View SEC Filing  
1/9/2014Mark GoldbergCOOSell6,901$46.49$320,827.49118,617View SEC Filing  
12/12/2013Xavier FlinoisInsiderBuy5,000$41.11$205,550.0011,800View SEC Filing  
9/11/2013Patrick FortuneDirectorSell7,000$48.31$338,170.0022,182View SEC Filing  
8/28/2013Richard LoveDirectorSell5,000$47.04$235,200.0090,741View SEC Filing  
6/4/2013Douglas A BattSVPSell15,000$45.15$677,250.00View SEC Filing  
6/3/2013Mark A GoldbergCOOSell15,000$45.06$675,900.00View SEC Filing  
5/20/2013Richard L LoveDirectorSell8,000$46.65$373,200.00View SEC Filing  
5/14/2013A Dana Callow JrDirectorSell8,000$46.39$371,120.00View SEC Filing  
5/13/2013Mark A GoldbergCOOSell28,887$45.19$1,305,403.53View SEC Filing  
5/10/2013Anita CooperVPSell10,000$44.99$449,900.00View SEC Filing  
5/9/2013Ulf I SchneiderSVPSell20,510$44.54$913,515.40View SEC Filing  
10/4/2012Mark A GoldbergCOOSell5,000$32.00$160,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PAREXEL International (NASDAQ PRXL) News Headlines

Source:
DateHeadline
Comparing Alkermes (ALKS) and PAREXEL International (PRXL)Comparing Alkermes (ALKS) and PAREXEL International (PRXL)
www.americanbankingnews.com - January 27 at 3:32 AM
Reviewing PAREXEL International (PRXL) & Crispr Therapeutics (CRSP)Reviewing PAREXEL International (PRXL) & Crispr Therapeutics (CRSP)
www.americanbankingnews.com - December 15 at 8:45 AM
PAREXEL Launches Perceptive® Cloud for the Life Sciences IndustryPAREXEL Launches Perceptive® Cloud for the Life Sciences Industry
finance.yahoo.com - December 12 at 10:50 AM
PAREXEL International Co. (PRXL) Given Average Recommendation of "Hold" by BrokeragesPAREXEL International Co. (PRXL) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 27 at 4:28 PM
Head to Head Review: Senomyx (SNMX) & PAREXEL International (PRXL)Head to Head Review: Senomyx (SNMX) & PAREXEL International (PRXL)
www.americanbankingnews.com - November 19 at 11:34 AM
PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology IndustryPAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
finance.yahoo.com - November 18 at 11:02 AM
PAREXEL International (PRXL) vs. INC Research Holdings (INCR) Critical SurveyPAREXEL International (PRXL) vs. INC Research Holdings (INCR) Critical Survey
www.americanbankingnews.com - November 5 at 7:16 PM
Reviewing PAREXEL International (PRXL) & Its CompetitorsReviewing PAREXEL International (PRXL) & Its Competitors
www.americanbankingnews.com - November 3 at 5:32 AM
PAREXEL International Co. (PRXL) Given Consensus Recommendation of "Hold" by BrokeragesPAREXEL International Co. (PRXL) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 2 at 5:48 PM
Analyzing PAREXEL International Corporation (PRXL) and Its RivalsAnalyzing PAREXEL International Corporation (PRXL) and Its Rivals
www.americanbankingnews.com - October 17 at 12:54 PM
PAREXEL International Corporation (PRXL) to Release Earnings on TuesdayPAREXEL International Corporation (PRXL) to Release Earnings on Tuesday
www.americanbankingnews.com - October 17 at 6:26 AM
PAREXEL International Corporation (PRXL) Given Average Recommendation of "Hold" by BrokeragesPAREXEL International Corporation (PRXL) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 8 at 2:44 PM
Pamplona Capital Management Completes Acquisition of PAREXEL InternationalPamplona Capital Management Completes Acquisition of PAREXEL International
www.marketwatch.com - September 29 at 6:18 PM
Six Flags Entertainment and Sterling Bancorp Set to Join S&P MidCap 400; Oil States Intl. and KEMET to Join S&P SmallCap 600Six Flags Entertainment and Sterling Bancorp Set to Join S&P MidCap 400; Oil States Intl. and KEMET to Join S&P SmallCap 600
finance.yahoo.com - September 26 at 7:05 PM
PAREXEL International Corporation (PRXL) & Exact Sciences Corporation (EXAS) Financial ComparisonPAREXEL International Corporation (PRXL) & Exact Sciences Corporation (EXAS) Financial Comparison
www.americanbankingnews.com - September 24 at 12:20 AM
PAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital ManagementPAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management
finance.yahoo.com - September 19 at 6:44 AM
$538.12 Million in Sales Expected for PAREXEL International Corporation (PRXL) This Quarter$538.12 Million in Sales Expected for PAREXEL International Corporation (PRXL) This Quarter
www.americanbankingnews.com - September 14 at 10:05 AM
PAREXEL International Corporation (PRXL) Given Average Rating of "Hold" by AnalystsPAREXEL International Corporation (PRXL) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - September 13 at 4:46 PM
ETFs with exposure to PAREXEL International Corp. : September 7, 2017ETFs with exposure to PAREXEL International Corp. : September 7, 2017
finance.yahoo.com - September 8 at 7:17 AM
PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New TreatmentsPAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
finance.yahoo.com - September 7 at 7:52 AM
PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New TreatmentsPAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
finance.yahoo.com - September 7 at 7:52 AM
PAREXEL International Corp. :PRXL-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017PAREXEL International Corp. :PRXL-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017
finance.yahoo.com - September 2 at 7:43 AM
Brokers Issue Forecasts for PAREXEL International Corporations Q1 2018 Earnings (PRXL)Brokers Issue Forecasts for PAREXEL International Corporation's Q1 2018 Earnings (PRXL)
www.americanbankingnews.com - August 31 at 10:39 AM
After-Hours Earnings Report for August 28, 2017 : PRXL, CTLT, PSEC, AMSWA, EXA, PRCP - NasdaqAfter-Hours Earnings Report for August 28, 2017 : PRXL, CTLT, PSEC, AMSWA, EXA, PRCP - Nasdaq
www.nasdaq.com - August 29 at 6:54 AM
Parexel beats Street 4Q forecasts - Yahoo Finance - Yahoo FinanceParexel beats Street 4Q forecasts - Yahoo Finance - Yahoo Finance
finance.yahoo.com - August 29 at 6:54 AM
Parexel beats Street 4Q forecastsParexel beats Street 4Q forecasts
finance.yahoo.com - August 29 at 6:54 AM
PAREXEL International Corporation (PRXL) Posts  Earnings Results, Beats Expectations By $0.09 EPSPAREXEL International Corporation (PRXL) Posts Earnings Results, Beats Expectations By $0.09 EPS
www.americanbankingnews.com - August 28 at 8:22 PM
PAREXEL International Corporation (PRXL) Short Interest UpdatePAREXEL International Corporation (PRXL) Short Interest Update
www.americanbankingnews.com - August 28 at 1:48 AM
PAREXEL International Corporation (PRXL) Expected to Announce Quarterly Sales of $537.57 MillionPAREXEL International Corporation (PRXL) Expected to Announce Quarterly Sales of $537.57 Million
www.americanbankingnews.com - August 26 at 11:52 AM
 Analysts Anticipate PAREXEL International Corporation (PRXL) to Post $0.94 EPS Analysts Anticipate PAREXEL International Corporation (PRXL) to Post $0.94 EPS
www.americanbankingnews.com - August 24 at 2:10 PM
PAREXEL Ties Up With Osaka International Cancer InstitutePAREXEL Ties Up With Osaka International Cancer Institute
finance.yahoo.com - August 22 at 4:02 PM
PAREXEL International Corporation (PRXL) Set to Announce Quarterly Earnings on MondayPAREXEL International Corporation (PRXL) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - August 22 at 10:30 AM
PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in JapanPAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
finance.yahoo.com - August 22 at 6:03 AM
PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in JapanPAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
finance.yahoo.com - August 22 at 6:03 AM
SHAREHOLDER ALERT: Rigrodsky & Long, PA Files Class Action Suit Against PAREXEL International Corporation - GlobeNewswire (press release)SHAREHOLDER ALERT: Rigrodsky & Long, PA Files Class Action Suit Against PAREXEL International Corporation - GlobeNewswire (press release)
globenewswire.com - August 17 at 3:22 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International ... - PR Newswire (press release)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International ... - PR Newswire (press release)
www.prnewswire.com - August 17 at 3:22 PM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against PAREXEL International CorporationSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against PAREXEL International Corporation
feeds.benzinga.com - August 15 at 9:28 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International Corporation - PRXLSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PAREXEL International Corporation - PRXL
finance.yahoo.com - August 15 at 6:25 AM
Novavax (NVAX) & PAREXEL International Corporation (PRXL) Financial AnalysisNovavax (NVAX) & PAREXEL International Corporation (PRXL) Financial Analysis
www.americanbankingnews.com - August 14 at 8:42 AM
Short Interest in PAREXEL International Corporation (NASDAQ:PRXL) Declines By 30.5%Short Interest in PAREXEL International Corporation (NASDAQ:PRXL) Declines By 30.5%
www.americanbankingnews.com - August 14 at 2:14 AM
See what the IHS Markit Score report has to say about PAREXEL International Corp.See what the IHS Markit Score report has to say about PAREXEL International Corp.
finance.yahoo.com - August 13 at 4:07 AM
IHS Markit Score Update: Drop in demand for ETFs holding PAREXEL International Corp is a negative sign for its sharesIHS Markit Score Update: Drop in demand for ETFs holding PAREXEL International Corp is a negative sign for its shares
finance.yahoo.com - August 11 at 7:45 AM
PAREXEL International Corporation -- Moodys assigns a B2 CFR to PAREXEL; outlook stablePAREXEL International Corporation -- Moody's assigns a B2 CFR to PAREXEL; outlook stable
finance.yahoo.com - August 9 at 6:34 AM
PAREXEL International Corporation Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.PAREXEL International Corporation Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.
finance.yahoo.com - August 8 at 6:21 AM
Two PAREXEL Executives Named to 2017 PharmaVOICE 100Two PAREXEL Executives Named to 2017 PharmaVOICE 100
finance.yahoo.com - August 2 at 6:50 AM
PAREXEL International Corporation (PRXL) Given Consensus Rating of "Hold" by AnalystsPAREXEL International Corporation (PRXL) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - July 25 at 4:51 PM
Stock Performance Review on Medical Labs & Research Industry -- PAREXEL, China Cord Blood, ICON, and PRA ... - PR Newswire (press release)Stock Performance Review on Medical Labs & Research Industry -- PAREXEL, China Cord Blood, ICON, and PRA ... - PR Newswire (press release)
www.prnewswire.com - July 20 at 6:26 AM
Short Interest in PAREXEL International Corporation (PRXL) Drops By 58.3%Short Interest in PAREXEL International Corporation (PRXL) Drops By 58.3%
www.americanbankingnews.com - July 16 at 7:22 AM
PAREXEL International Corporation (PRXL)PAREXEL International Corporation (PRXL)
seekingalpha.com - July 12 at 7:08 AM
PAREXEL Receives CEO Cancer Gold Standard Re-AccreditationPAREXEL Receives CEO Cancer Gold Standard Re-Accreditation
finance.yahoo.com - July 12 at 7:08 AM

SEC Filings

PAREXEL International (NASDAQ:PRXL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PAREXEL International (NASDAQ:PRXL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PAREXEL International (NASDAQ PRXL) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.